ATROPINA

Mydriatic-Cycloplegic

Atropine

Composition

Each ml of sterile ophthalmic solution contains:
Atropine sulfate 10 mg (1%)
Excipients q.s.

Atropine sulfate 5 mg (0,5%)
Excipients q.s.

Presentations

Sealed bottle containing 10 ml of sterile ophthalmic solution

Indications

The ophthalmic preparations of Atropina are used to produce mydriasis and cyclopegia during retinal and optic disc examination, together with the refractive error measurement.

Atropina is also used in the management of acute inflammatory processes of the iris (iridociclytis), and the uveal tract (uveitis). Atropina is also used for its cyclopegic effect for the treatment of amblyopia suppression by reducing visual acuity in the non-affected eye, while the affected eye forces fixation. It has also been used to treat patients with a functional excess of accommodation and convergence.